Next Article in Journal
Distribution and Clonal Diversity of Staphylococcus aureus and Other Staphylococci in Surface Waters: Detection of ST425-t742 and ST130-t843 mecC-Positive MRSA Strains
Next Article in Special Issue
Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials
Previous Article in Journal
Predictor of Early Administration of Antibiotics and a Volume Resuscitation for Young Infants with Septic Shock
Previous Article in Special Issue
Containment of Phytoplasma-Associated Plant Diseases by Antibiotics and Other Antimicrobial Molecules
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Resistance to 16-Membered Macrolides, Tiamulin and Lincomycin in a Swine Isolate of Acholeplasma laidlawii

1
Microbiología, Facultad de Ciencias de la Salud, Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas, Spain
2
Unidad de Epidemiología y Medicina Preventiva, Instituto Universitario de Sanidad Animal y Seguridad Alimentaria (IUSA), Universidad de Las Palmas de Gran Canaria, 35413 Arucas, Spain
*
Author to whom correspondence should be addressed.
Submission received: 29 September 2021 / Revised: 11 November 2021 / Accepted: 15 November 2021 / Published: 19 November 2021

Abstract

:
Acholeplasma (A.) laidlawii is an opportunistic pathogen with the ability to disseminate resistance determinants to antibiotics; however, its resistance to macrolides has been less studied. The aim of the present study was to characterize the mechanisms responsible for the resistance to macrolides, tiamulin and lincomycin found in a strain of A. laidlawii isolated from a pig with pneumonia. MICs of erythromycin, 15- and 16-membered macrolides, tiamulin and lincomycin were determined by microdilution method with and without reserpine, an inhibitor of ABC efflux pumps and regions of the genome were sequenced. Reserpine only decreased lincomycin MIC but it did not change the MICs of macrolides and tiamulin. The analysis of the DNA sequence of 23S rRNA showed nucleotide substitutions at eight different positions, although none of them were at positions previously related to macrolide resistance. Five mutations were found in the L22 protein, one of them at the stop codon. In addition, two mutations were found in the amino acid sequence of L4. The combination of multiple mutations in the ribosomal proteins L22 and L4 together with substitutions in 23S rRNA DNA sequence was associated with the resistance to macrolides, the pleuromutilin and lincomycin in the studied A. laidlawii strain.

1. Introduction

Acholeplasma (A.) laidlawii, a species of the class Mollicutes, is universally disseminated, having been first isolated from wastewaters in 1936 [1]. It colonizes animals, plants and insects, and it is a frequent contaminant in cell cultures and vaccine preparations [2,3,4,5]. It is frequently found as commensal of the mucosa in the upper respiratory and in the urogenital tract in animals, although it is able to cause opportunistic infections such as bovine mastitis [6,7,8]. In addition, the inoculation of A. laidlawii PG-8 into the teat canal resulted in clinical mastitis and agalactia in goats and sheep [8,9]. Likewise, its intranasal inoculation was associated with the development of arthritis and respiratory distress in lambs [9]. A. laidlawii has been also isolated from both normal and pneumonic lungs of pigs [10] and nasal secretion, trachea, and lung of calves [11].
Resistance to fluoroquinolones has been further studied in in vitro selected mutants of A. laidlawii, especially in relation to the ability of this species to produce extracellular vesicles carrying target genes of fluoroquinolones in addition to the presence of genes responsible for the development of resistance to beta-lactams in other bacterial species [12,13]. Resistance to macrolides other than erythromycin [14] in clinical isolates has not been described in Acholeplasma species, although multiple drug-resistant strains can be easily selected in vitro [15]. In the present work, we characterized the substitutions in DNA encoding 23S-ribosomal RNA and mutations in the ribosomal proteins L22 and L4 in a Macrolide-Lincosamide-Pleuromutilin (MLP)-resistant A. laidlawii strain isolated from the nostrils of a pig with pneumonia.

2. Results

PCR analysis of nucleotide sequence of 16S rRNA and the 16S-23S rRNA intergenic spacer region confirmed A. laidlawii species identification. MICs for 470 wild strain of all the 15- and 16-membered macrolides were ≥32 mg/L and erythromycin and lincomycin MICs were 2048 and 4096 mg/L, respectively, whereas MICs of the 15- and 16-membered macrolides and lincomycin ranged < 0.25–1 mg/L for the type strain PG8, with the exception of erythromycin, which produced a similar value to that observed for the wild strain (2048 mg/L). Reserpine 20 mg/L did not increase the susceptibility of the 470 strain to macrolides, tiamulin and lincomycin (Table 1).
Multiple nucleotide substitutions were found in DNA sequences of the 23S rRNA and the proteins L22 and L4 codifying genes. The analysis of the 23S rRNA DNA sequence showed nucleotide substitutions at eight different positions with respect to A. laidlawii PG-8A, shown in the corresponding domains (Table 2) following Escherichia (E.) coli numbering [16]. Furthermore, ten nucleotide substitutions were found in the DNA sequence of L22 (A70T, T84C, T144A, G279A, A312T, G322A, C323G, G325A, A328G, T334A), six of which resulted in amino acid changes (Table 2). In addition, thirteen nucleotide substitutions were found in the DNA sequence of L4 (A67T, T68C, C123A, C171T, G318A, A357T, A360T, A390T, T426C, T468A, G517T, T522A, A540G), although only three of them resulted in amino acid changes in the L4 protein (Table 2).

3. Discussion

The family Acholeplasmataceae is composed of the genus Acholeplasma and the phytoplasmas which have evolved by further degenerative evolution. It has been demonstrated that A. laidlawii and phytoplasmas can infect plants in a similar way. Phytoplasmas are characterized by their high genomic plasticity that allows them the acquisition and loss of genes that can result in the carriage of adhesion and virulence factors and the colonization and survival in a broad range of environments and hosts [1]. Within this family, A. laidlawii is the most studied species [1] and it is considered to be a hypermutable microorganism [5].
A. laidlawii strain 470 was isolated from the nostril exudate of a pig with pneumonia. PCR and sequencing analysis confirmed the species, including the characteristic double band for the intergenic spacer region, as previously described [17,18]. Although the species is more commonly associated with mastitis, previous studies have also isolated it from nasal secretions [11]. Strain 470 was resistant to erythromycin and clarithromycin due to the transition A2057G (E. coli numbering) in the nucleotide sequence 2056-GGAAAGAC-2063 of domain V of the 23S rRNA-encoding DNA. The G-to-A transition at position 2057 (E. coli numbering) was previously associated with the intrinsic resistance to 14-membered ring macrolides including erythromycin and clarithromycin in M. pulmonis, M. hyopneumoniae, and M. flocculare [19,20]. The same transition A2057G (E. coli numbering) was found in 23S rRNA DNA sequences of the type strain A. laidlawii PG-8A NC_010163.1 (75178.78004) and in strain 470 associated with erythromycin MICs of 2048 mg/L. In addition, the MIC values for erythromycin described for the type strain PG8 further support the potential role of intrinsic resistance in A. laidlawii to this antibiotic. Azithromycin MIC in strain 470 was 4- to 64-fold higher than those described in M. fermentans PG28, M. pulmonis UAB CTIP and M. hominis PG21 which are strains with the substitution A2057G in the 23S rRNA DNA sequence [19], although azithromycin MIC in M. hominis PG21 was also described to be 4- to 16-fold higher than in M. pulmonis UAB CTIP and M. fermentans PG28, respectively [19]. Likewise, strain 470 was resistant to the assayed 16-membered macrolides tylosin and tilmicosin, since MIC values of the above 16-membered macrolides were ≥16 mg/L, as was previously described [21]. Strain 470 was also resistant to the pleuromutilin tiamulin and to lincomycin. Previous reports support the role of ABC transporters in the resistance to antibiotics in mollicutes [13], in this regard ABC-type efflux pump has been involved in macrolide resistance in M. pneumoniae [22]. Furthermore, the role of ATP-dependent efflux pumps in resistance to ciprofloxacin in A. laidlawii was previously described [23]. The inhibition of ATP-dependent active efflux by the use of reserpine 20 mg/L, an inhibitor de ATP-dependent active efflux in mycoplasmas [24], only decreased lincomycin MIC in strain 470.
The search of mechanisms responsible for the high level of resistance to macrolides and lincomycin in strain 470 revealed eight nucleotide substitutions in the 23S rRNA-encoding DNA, although they were not at positions 2058 and 2059 (E. coli numbering), which are strongly associated with resistance to 16-membered macrolides [25], neither in other nucleotides of 2056-GGAAAGAC-2063 (E. coli numbering) except the G2057A transition, unlike previous descriptions on 16-membered macrolide-resistant mycoplasmas [25]. There was neither substitution at position 2611 (E. coli numbering) in the 23S rRNA-encoding DNA, which has been also associated with a low level of resistance to Macrolides Lincosamides Streptogramins Ketolides (MLSK) [25].
Single amino acid changes in conserved regions of L4 and L22 proteins have been previously described in mycoplasmas resistant to macrolides [25,26]. Mutations in L4 and L22 can modify the macrolide-binding site [27]. In this regard, a previous description found that the suppression of four amino acids between threonine 110 and lysine 115 in L22 of M. pneumoniae resulted in the complete loss of telithromycin activity, a semi-synthetic erythromycin derivative [20]. However, the four amino acids occupying the equivalent position in L22 of A. laidlawii PG-8A, those between methionine 85 and lysine 90, were not mutated in strain 470. Conversely, ten nucleotide substitutions were identified in L22 of strain 470 and six of them resulted in amino acid changes including non-stop mutation at position 112 that generated a protein with an extreme length and probably with a distortion of the target of macrolides. The mutated L22 protein did not prevent the growth of strain 470, as previously described in a strain of Bacillus subtilis in which the inactivation of the gene encoding L22 protein did not avoid cell proliferation [28]. Likewise, two mutations were found in L4. We hypothesize a possible perturbation in the global folding of rRNA during 50S subunit assembly in strain 470 by the interaction of mutated L22 and L4 with rRNA resulting in macrolides, tiamulin and lincomycin resistance. In fact, a genotype consisting of single and double nucleotide substitutions in the domain II of the 23S rRNA DNA together with a single mutation in L22 was described associated with tylosin MICs ≥ 8 mg/L and tilmicosin MIC ≥ 128 mg/L in M. bovis [27], corresponding to 702 and 706 nucleotides in domain II and Leu86 in L22 of A. laidlawii PG8-A, although changes in these last positions were not identified in strain 470. Furthermore, the presence of Lys at position 90 in L22 (Lys90) in the reference strain A. laidlawii PG-8A was not associated with macrolide-lincosamide resistance, unlike the single mutation Arg97Lys in L22 in M. hominis associated with the macrolide-lincosamide-streptogramin B (MLSB) resistance phenotype [20]. There are multiple descriptions of mutations in L4 and L22 ribosomal proteins that have been associated with macrolide resistance in several Mycoplasma species [12,29]. Strain 470 showed five and two mutations in L22 and L4, respectively, which has not been previously described. It is possible that some or all of these mutations were able to influence the functionally active three-dimensional structure of 23S rRNA at multiple sites, as Gregory and Dahlberg (1999) [30] suggested for E. coli, impacting macrolides, tiamulin and lincomycin binding and resulting in resistance to them.
To our knowledge, this is the first report on a multi-drug resistant clinical isolate of A. laidlawii from a pig carrying multiple mutations in the 50S ribosomal proteins L22 and L4 and nucleotide substitutions in the DNA sequence of 23S rRNA. The combination of multiple mutations in the ribosomal proteins L22 and L4 together with substitutions in 23S rRNA DNA sequence were associated with increased resistance against macrolides; however, these findings must be confirmed by introducing these mutations individually and/or in combination into the susceptible strain of A. laidlawii. The challenge of a possible spread of resistant A. laidlawii strains helped by their genomic plasticity should not be overlooked.

4. Materials and Methods

4.1. A. laidlawii Strains

A. laidlawii 470 was isolated from the nostrils of a pig with pneumonia from an Italian farm in 2016. Tylosin, tiamulin tilmicosin and tylvalosin were routinely used for the systemic treatment of pneumonia on this farm. Those antibiotics were used alternatively during the production cycle. The field strain was isolated in Friis medium supplemented with horse and porcine sera and without antibiotics as described and filtered and cloned to ensure purity [31,32]. The strain was identified by their morphologic and biochemical properties [33], and the identification was confirmed by PCR by sequencing 16S rRNA, 23S rRNA and the 16S to 23S rRNA intergenic spacer region, as described below. We used A. laidlawii strain PG8T as a control strain for MIC determinations, obtained from the collection of microorganisms of Mycoplasma Experience Ltd. (Surrey, UK).

4.2. Antimicrobials

The antimicrobial agents used in this study included tilmicosin, clarithromycin, azithromycin, erythromycin and tiamulin from Fluka Analytical (St. Louis, MO, USA), tylosin from Serva (Heidelberg, Germany) and lincomycin, a lincosamide, from Sigma (St. Louis, MO, USA). The stock antibiotic solutions were sterilized by filtration through 0.2 µm pore size membrane filters (Millipore, Madrid, Spain).

4.3. Determination of MICs

MICs of erythromycin and clarithromycin, two 14-membered ring macrolides and azithromycin a 15-membered ring macrolide, and MICs of the 16-membered ring macrolides tylosin and tilmicosin, the pleuromutilin tiamulin and the lincosamide lincomycin were determined by using the broth microdilution method, as previously described [34], modified by using Friis medium supplemented with 0.2% phenol red and 1% glucose. Serial twofold dilutions of each antibiotic ranging from 0.003 to 256 mg/L were prepared for 15- and 16-membered macrolides and tiamulin and 0.12 to 4096 mg/L for erythromycin and lincomycin in sterilized microdilution plates. MICs were determined in strains 470 and PG8T at the same time and in the same conditions, as previously described [32,34]. The strains were tested in duplicate on three different days for each agent, with and without reserpine 20 mg/L, which has been proved to be sufficient to inhibit adenosine triphosphate (ATP)-binding cassette (ABC) efflux pumps in mycoplasma strains [34,35].

4.4. Polymerase Chain Reaction Amplification and Sequencing

Genomic DNA was extracted from A. laidlawii 470 culture using an UltraClean Microbial DNA isolation Kit (MO BIO Laboratories, Carlsbad, CA USA). PCR analysis of the nucleotide sequence of the 16S rRNA and the 16S to 23S rRNA intergenic spacer region for species identification were performed as previously described [36,37]. Likewise, different primers were designed by using as reference the sequences of A. laidlawii PG-8A present at GenBank Database and used for the complete amplification of DNA encoding 23S ribosomal RNA NC_010163.1 (75178.78004), as well as DNA sequences of proteins L22 NC_010163.1 (87002.87337) and L4 NC_010163.1 (84911. 85534) of the 50S ribosomal subunit (Table 3). The PCR products were purified using the E.Z.N.A. cycle pure kit, MO BIO Laboratories, California (USA). Finally, purified PCR products were sequenced by an external service (Macrogen, Madrid, Spain). Nucleotides sequences were analyzed using BLAST online service (https://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed on 21 November 2019).

5. Conclusions

Mutations in five amino acids were found in L22, one of them in the stop codon that resulted in an extremely long and probably dysfunctional protein, in conjunction with mutations in L4 and substitutions in 23S rRNA DNA sequence were associated with the resistance profile to macrolides, the pleuromutilin and lincomycin in the studied A. laidlawii strain 470.

Author Contributions

Conceptualization, M.M.T., A.S.R., R.S.R. and J.B.P.; methodology, C.P. and C.F.M.; validation, M.M.T., A.S.R. and J.B.P.; investigation, C.P. and C.F.M.; resources, M.M.T., J.B.P. and A.S.R.; writing—original draft preparation, M.M.T. and J.B.P.; writing—review and editing, A.S.R. and R.S.R.; supervision, M.M.T., A.S.R. and J.B.P.; project administration, M.M.T. and A.S.R.; funding acquisition, M.M.T. and A.S.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Ministerio de Ciencia, Innovación y Universidades with the project numbers GOB-ESP2019-02 and GOB-ESP2019-09.

Data Availability Statement

The data presented in this study are available on reasonable request from the corresponding author.

Acknowledgments

We would like to thank Helena Windsor for providing us the Acholeplasma laidlawii PG8T.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Lazarev, V.N.; Levitskii, S.A.; Basovskii, Y.I.; Chukin, M.M.; Akopian, T.A.; Vereshchagin, V.V.; Kostrjukova, S.; Kovaleva, G.Y.; Kazanov, M.D.; Malko, D.B.; et al. Complete genome and proteome of Acholeplasma laidlawii. J. Bacteriol. 2011, 193, 4943–4953. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Ayling, R.D.; Bashiruddin, S.E.; Nicholas, R.A.J. Mycoplasma species and related organisms isolated from ruminants in Britain between 1990 and 2000. Vet. Rec. 2004, 155, 413–416. [Google Scholar] [CrossRef] [PubMed]
  3. Ishikawa, Y.; Kozakai, T.; Morita, H.; Saida, K.; Oka, S.; Masuo, Y. Rapid detection of mycoplasma contamination in cell cultures using SYBR green-based real-time polymerase chain reaction. In Vitro Cell. Dev. Biol. Anim. 2006, 42, 63–69. [Google Scholar] [CrossRef]
  4. Windsor, H.M.; Windsor, G.D.; Noordergraaf, J.H. The growth and long-term survival of Acholeplasma laidlawii in media products used in biopharmaceutical manufacturing. Biologicals 2010, 38, 204–210. [Google Scholar] [CrossRef]
  5. Mouzykantov, A.; Medvedeva, E.; Baranova, N.; Lopuhov, V.; Usachev, K.; Chernova, O.; Chernov, V. Data on the genome and proteome profiles of ciprofloxacin-resistant Acholeplasma laidlawii strains selected under different conditions in vitro. Data Brief 2020, 33, 106412. [Google Scholar] [CrossRef] [PubMed]
  6. Counter, D.E. A severe outbreak of bovine mastitis associated with Mycoplasma bovigenitalium and Acholeplasma laidlawii. Vet. J. 1978, 103, 130–131. [Google Scholar]
  7. Hauk, H. Studies of Mycoplasma mastitis in cattle. 5. Studies of udder pathogenicity of Mycoplasma and Acholeplasma strains of different origins. Arch. Exp. Vet. 1979, 33, 665–673. [Google Scholar]
  8. Singh, A.; Gupta, P.P.; Banga, H.S. Pathogenicity of Acholeplasma laidlawii for the goat udder. Aust. Vet. J. 1990, 67, 155–156. [Google Scholar] [CrossRef]
  9. De la Concha-Bermejillo, A.; Magnus-Corral, S.; Brodie, S.J.; Rossenbusch, R.F.; DeMartini, J.C. Pathologic responses of lambs to experimental inoculation with Acholeplasma laidlawii. J. Vet. Diagn. Investig. 1996, 8, 115–118. [Google Scholar] [CrossRef] [Green Version]
  10. Tiong, S.K.; Sing, K.Y. Isolation and identification of mycoplasmas from pig lungs in Singapore. Vet. Rec. 1981, 108, 75–77. [Google Scholar] [CrossRef]
  11. Hiroe, K.; Kobayashi, H.; Ito, N.; Kawasaki, Y.; Zako, M.; Kotani, K.; Ogawa, H.; Sato, H. Isolation of Mycoplasmas from nasal swabs of calves affected with respiratory diseases and antimicrobial susceptibility of their isolates. J. Vet. Med. 2003, 50, 347–351. [Google Scholar] [CrossRef] [PubMed]
  12. Chernova, O.A.; Medvedeva, E.S.; Moutzykantov, A.A.; Baranova, N.B.; Chernov, V.M. Mycoplasmas and their antibiotic resistance: The problems and prospects in controlling infections. Acta Nat. 2016, 8, 24–34. [Google Scholar] [CrossRef] [Green Version]
  13. Chernov, V.M.; Chernova, O.A.; Mouzykantov, A.A.; Medvedeva, E.S.; Baranova, N.B.; Malygina, T.Y.; Aminov, R.I.; Trushin, M.V. Antimicrobial resistance in mollicutes: Known and newly emerging mechanisms. FEMS Microbiol. Lett. 2018, 365, fny185. [Google Scholar] [CrossRef] [PubMed]
  14. Umera, R.; Sueyoshi, M.; Nagatomo, H. Antimicrobial susceptibilities of four species of Mycoplasma isolated in 2008 and 2009 from cattle in Japan. J. Vet. Med. Sci. 2010, 72, 1661–1663. [Google Scholar] [CrossRef] [Green Version]
  15. Hashimoto, R.; Nakamura, M. Selection and propagation of antibiotic-resistant mutants of Acholeplasma by the addition of fresh culture medium containing antibiotics and protease to the medium cultured with Acholeplasma. Kurume Med. J. 1985, 32, 15–20. [Google Scholar] [CrossRef] [PubMed]
  16. Petrov, A.S.; Bernier, C.R.; Hershkovits, E.; Xue, Y.; Waterbury, C.C.; Hsiao, C.; Stepanov, V.G.; Gaucher, E.A.; Grover, M.A.; Harvey, S.C.; et al. Secondary structure and domain architecture of the 23S and 5S rRNAs. Nucleic Acid Res. 2013, 41, 7522–7535. [Google Scholar] [CrossRef] [PubMed]
  17. Tang, J.; Hu, M.; Lee, S.; Roblin, R. A polymerase chain reaction based for detecting Mycoplasma/Acholeplasma contaminants in cell culture. J. Microbiol. Methods 2000, 39, 121–126. [Google Scholar] [CrossRef]
  18. Volokhov, D.; George, J.; Liu, S.; Ikonomi, P.; Anderson, C.; Chizhikov, V. Sequencing of the intergenic 16S-23S rRNA spacer (ITS) region of Mollicutes species and their identification using microarray-based assay and DNA sequencing. Appl. Microbiol. Biotechnol. 2006, 71, 680–698. [Google Scholar] [CrossRef]
  19. Pereyre, S.; Gonzalez, P.; De Barbeyrac, B.; Darnige, A.; Renaudin, H.; Charron, A.; Raherison, S.; Bébéar, C.; Bébéar, C.M. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob. Agents Chemother. 2002, 46, 3142–3150. [Google Scholar] [CrossRef] [Green Version]
  20. Pereyre, S.; Renaudin, H.; Charron, A.; Bébéar, C.; Bébéar, C.M. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin. J. Antimicrob. Chemother. 2006, 57, 753–756. [Google Scholar] [CrossRef] [Green Version]
  21. Hannan, P.C.T.; Windsor, G.D.; De Jong, A.; Schmeer, N.; Stegemann, M. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob. Agents Chemother. 1997, 41, 2037–2040. [Google Scholar] [CrossRef] [Green Version]
  22. Li, S.; Xue, G.; Zhao, H.; Feng, Y.; Yan, C.; Cui, J.; Xie, X.; Yuan, J. Quantitative proteomics analysis of Mycoplasma pneumoniae identifies potential macrolide resistance determinants. AMB Express 2021, 11, 26. [Google Scholar] [CrossRef] [PubMed]
  23. Nlu, A.; Govorum, V.M. The participation of the transport-barrier functions of the plasma membrane in the development of fluoroquinolone (ciprofloxacin) resistance in Acholeplasma laidlawii. Antibiot. Khimioterap. 2000, 45, 14–19. [Google Scholar]
  24. Antunes, N.T.; Assunção, P.; Poveda, J.B.; Tavío, M.M. Mechanisms involved in quinolone resistance in Mycoplasma mycoides subsp. capri. Vet. J. 2015, 204, 327–332. [Google Scholar] [CrossRef]
  25. Pereyre, S.; Goret, J.; Bébéar, C. Mycoplasma pneumoniae: Current knowledge on macrolide resistance and treatment. Front. Microbiol. 2016, 7, 974. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Pereyre, S.; Guyot, C.; Renaudin, H.; Charron, A.; Bébéar, C.; Bébéar, C.M. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 2004, 48, 460–465. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Lerner, U.; Amram, E.; Ayling, R.D.; Mikula, I.; Gerchman, I.; Harrus, S.; Tewff, D.; Yogev, D.; Lysnyanski, I. Acquired resistance to the 16-membered macrolides tylosin and tilmicosin by Mycoplasma bovis. Vet. Microbiol. 2014, 168, 365–671. [Google Scholar] [CrossRef]
  28. Akanuma, G.; Nanamiya, H.; Natori, Y.; Yano, K.; Suzuki, S.; Omata, S.; Ishizuka, M.; Sekine, Y.; Kawamura, F. Inactivation of ribosomal protein genes in Bacillus subtilis reveals importance of each ribosomal protein for cell proliferation and cell differentiation. J. Bacteriol. 2012, 194, 6282–6291. [Google Scholar] [CrossRef] [Green Version]
  29. Bébéar, C.; Pereyre, S.; Peuchant, O. Mycoplasma pneumoniae: Susceptibility and resistance to antibiotics. Future Microbiol. 2011, 6, 423–431. [Google Scholar] [CrossRef]
  30. Gregory, S.T.; Dahlberg, A.E. Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23S ribosomal RNA. J. Mol. Biol. 1999, 289, 827–834. [Google Scholar] [CrossRef]
  31. Tully, J.G. Test for digitonin sensitivity and sterol requeriment. In Methods in Mycoplasmology; Razin, S., Tully, J., Eds.; Academic Press: New York, NJ, USA, 1983; Volume 1, pp. 355–362. [Google Scholar]
  32. Tavío, M.M.; Poveda, C.; Assunção, P.; Ramírez, A.S.; Poveda, J.B. In vitro activity of tylvalosin against Spanish field strains of Mycoplasma hyopneumoniae. Vet. Rec. 2014, 175, 539. [Google Scholar] [CrossRef]
  33. Boonyayatra, S.; Fox, L.K.; Gay, J.M.; Sawant, A.; Besser, T.E. Discrimination between Mycoplasma and Acholeplasma species of bovine origin using digitonin disc diffusion assay, nisin disc diffusion assay, and conventional polymerase chain reaction. J. Vet. Diagn. Investig. 2012, 24, 7–13. [Google Scholar] [CrossRef]
  34. Antunes, N.T.; Tavío, M.M.; Mercier, P.; Ayling, R.D.; AI-Momani, W.; Assunção, P.; Rosales, R.S.; Poveda, J.B. In vitro susceptibilities of Mycoplasma putrefaciens field isolates. Antimicrob. Agents Chemother. 2007, 51, 3452–3454. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Raherison, S.; Gonzalez, P.; Renaudin, H.; Bébéar, C.; Bébéar, C.M. Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis. Antimicrob. Agents Chemother. 2002, 46, 672–679. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Ramírez, A.S.; Naylor, C.; Pitcher, D.; Bradbury, J. High inter-species and low intra-species variation in 16S-23S rDNA spacer sequences of pathogenic avian mycoplasmas offers potential use as a diagnostic tool. Vet. Microbiol. 2008, 128, 279–287. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Yavari, C.A.; Ramírez, A.S.; Nicholas, R.A.; Radford, A.D.; Darby, A.C.; Bradbury, J.M. Mycoplasma tullyi sp. nov., isolated from penguins of the genus Spheniscus. Int. J. Syst. Evol. Microbiol. 2017, 67, 3692–3698. [Google Scholar] [CrossRef]
Table 1. MICs of macrolides, tiamulin and lincomycin in Acholeplasma laidlawii PG8T and in 470 without and with reserpine 20 mg/L.
Table 1. MICs of macrolides, tiamulin and lincomycin in Acholeplasma laidlawii PG8T and in 470 without and with reserpine 20 mg/L.
MIC (mg/L)
AntibioticsA. laidlawii PG8TA. laidlawii 470
Erythromycin 20482048
Erythromycin + Reserpine * 20482048
Clarithromycin 0.2532
Clarithromycin + Reserpine -32
Azithromycin 0.125128
Azithromycin + Reserpine -128
Tylosin 0.2564
Tylosin + Reserpine -64
Tilmicosin 0.2564
Tilmicosin + Reserpine -128
Lincomycin <0.25>4096
Lincomycin + Reserpine -4096
Tiamulin 1.0128
Tiamulin + Reserpine -128
* Reserpine assay for A. laidlawii type strain PG8 was performed in order to evaluate the role of efflux pump for erythromycin resistance.
Table 2. Nucleotide substitutions in DNA encoding 23S ribosomal-RNA and mutations in the ribosomal proteins L22 and L4 in Acholeplasma laidlawii 470 comparing to type strain PG8.
Table 2. Nucleotide substitutions in DNA encoding 23S ribosomal-RNA and mutations in the ribosomal proteins L22 and L4 in Acholeplasma laidlawii 470 comparing to type strain PG8.
Nucleotide ChangesMutations
Strain23S Ribosomal RNA Domains 1L4L22
IIIIIIV
470G320AT1254G 2G1376A
G1450T
G1475A
G1579A
T2131A
T2133G
A67T
T68C
Ile23Ser
ATC→TCC
G517T
Ala173Ser
GCA→TCA
A70T
Ile24Phe
ATT→TTT
G322A
C323G
Ala108Arg
GCA→AGA
G325A
Glu109Lys
GAA→AAA
A328G
Arg110Gly
AGG→GGG
T334A
STOP112Lys
TAA→AAA
1 Nucleotide substitutions following Escherichia coli numbering and using the canonical 2° structure with 6 domains [16]. 2 This position is in Domain 0 based on a 3D structure with 7 domains [16].
Table 3. Primers used in the study for PCR and sequencing.
Table 3. Primers used in the study for PCR and sequencing.
GeneForward Oligonucleotide Sequences (5′-3′)Reverse Oligonucleotide Sequences (5′-3′)
23S-rRNAGAACAAAGGGCACACAGTGCTTGCTATGTAACATAACTCGC
GATGGCATGCCTTTTGTAGCAGAGTCACTCGACCAGTG
GCCATCCTTTAAAGAGTGCGCAACAGTTTTCTCGCGCGTC
GTAAACCGACACAGGTGGCAAACTGCCCACCAGACAC
CGTGCACTTAGTTTCTAACTTCCCAGTAAGCTGAATACATCGC
rplV1GAAGCTAAAGCAATTGGAAAAACCTCCCTTTCTGCGACAAC
rplD2GCCAACATTAAATTTATTCAATCCTCGTAGTATTTAACAGCAC
1 Gene encoding L22 ribosomal protein, 2 Gene encoding L4 ribosomal protein.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tavío, M.M.; Ramírez, A.S.; Poveda, C.; Rosales, R.S.; Malla, C.F.; Poveda, J.B. Resistance to 16-Membered Macrolides, Tiamulin and Lincomycin in a Swine Isolate of Acholeplasma laidlawii. Antibiotics 2021, 10, 1415. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics10111415

AMA Style

Tavío MM, Ramírez AS, Poveda C, Rosales RS, Malla CF, Poveda JB. Resistance to 16-Membered Macrolides, Tiamulin and Lincomycin in a Swine Isolate of Acholeplasma laidlawii. Antibiotics. 2021; 10(11):1415. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics10111415

Chicago/Turabian Style

Tavío, María M., Ana S. Ramírez, Carlos Poveda, Rubén S. Rosales, Cristina F. Malla, and José B. Poveda. 2021. "Resistance to 16-Membered Macrolides, Tiamulin and Lincomycin in a Swine Isolate of Acholeplasma laidlawii" Antibiotics 10, no. 11: 1415. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics10111415

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop